Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Visiongain's new report; Global Bioreactors Market 2019-2029

3 views

Published on

Page-163, in the report provides clear detailed insight into the global bioreactors market. Discover the key drivers and challenges affecting the market. By ordering and reading our brand-new report today you stay better informed and ready to act.

Published in: Business
  • Be the first to comment

  • Be the first to like this

Visiongain's new report; Global Bioreactors Market 2019-2029

  1. 1. ©notice This material is copyright by Visiongain. It is against the law to reproduce any of this material without the prior written agreement of visiongain.You cannot photocopy, fax, download to database or duplicate in any other way any of the material contained in this report. Each purchase and single copy is for personal use only. Global Bioreactors Market 2019-2029 5L-20L, 20L-200L, 200L-1500L, Above 1500L, Single-Use, Glass, Stainless Steel, Lab-Scale, Pilot-Scale, Full-Scale, R&D Departments, Biopharmaceutical Manufacturers, Contract Research Organizations, Other End-Users
  2. 2. www.visiongain.com/industries/pharma Page65 Global Bioreactors Market 2019-2029: 5L-20L, 20L-200L, 200L-1500L, Above 1500L, Single-Use, Glass, Stainless Steel, Lab-Scale, Pilot-Scale, Full-Scale, R&D Departments, Biopharmaceutical Manufacturers, Contract Research Organizations, Other End-Users Figure 6.5 Global 5L-20L Market Share by Region: (% Share) 2029 6.2 20L-200L Submarket Forecast & Analysis 2019-2029 There has been a constant rise in the importance of animal cell culture for the large-scale production of pharmaceutical products. However, the cells sensibility towards their cultivation environment still presents a challenging issue. As compared to the microbial cultures, cell cultures are not protected by a cell wall and therefore are more sensitive to shear stress and foam formation. Therefore, reactor design and selection of ‘robust’ cell lines are particularly significant for these conditions. The microbial sterilisable-in-place bioreactor systems come in variant volume of 20 liter, 40 liter, 70 liter and 140 liter. The different applications of these bioreactor systems include pilot plant and small- scale production for mammalian cells as well as micro-organisms. The first step in the scale-up to production level is pilot range and these systems have same functionality as full production scale. Therefore, it leads to minimum risks in process transfer to the final production volume. Factors such as increasing number of laboratories and technical innovations are leading to the high market share of this segment. However, regulatory hurdles are further hampering the market. North America 45% Europe 25% Asia-Pacific 19% RoW 11% Source: Visiongain 2018
  3. 3. www.visiongain.com/industries/pharma Page102 Global Bioreactors Market 2019-2029: 5L-20L, 20L-200L, 200L-1500L, Above 1500L, Single-Use, Glass, Stainless Steel, Lab-Scale, Pilot-Scale, Full-Scale, R&D Departments, Biopharmaceutical Manufacturers, Contract Research Organizations, Other End-Users 7.12.4 Rest of Asia-Pacific (APAC) Bioreactors Market Forecasts 2019-2029 The rest of Asia-Pacific market constitutes around 22% of the total Asia-Pacific market in 2017. Factors such as the soaring demand for biopharmaceutical drugs for the treatment of various disorders, rise in the biotechnology sector and increasing research activities in this sector are fuelling the growth of this market. Figure 7.25 Rest of Asia-Pacific (APAC) Bioreactors Market Forecasts ($m), 2017-2029 Table 7.22 Rest of Asia-Pacific (APAC) Bioreactors Market Forecasts: ($m, AGR% CAGR%) 2017-2029 The Rest of Asia-Pacific (APAC) bioreactors market is calculated to be worth $43.08m in 2017. This value will grow to $62.3m in 2023 and it is expected to reach $93.2m in 2029. The CAGR for the Rest of Asia-Pacific bioreactors market from 2017-2029 is expected to be 6.6%. 6.0% 6.1% 6.2% 6.2% 6.4% 6.5% 6.6% 6.8% 6.9% 7.1% 7.1% 7.0% 6.8% 5.5% 5.7% 5.9% 6.1% 6.3% 6.5% 6.7% 6.9% 7.1% 7.3% 0 20 40 60 80 100 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 Revenue($m) Rest of APAC AGR (%) Country 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 Rest of APAC 43.08 45.71 48.53 51.54 54.84 58.43 62.30 66.57 71.15 76.18 81.61 87.30 93.25 AGR(%) 6.0% 6.1% 6.2% 6.2% 6.4% 6.5% 6.6% 6.8% 6.9% 7.1% 7.1% 7.0% 6.8% CAGR(2017 - 2022) CAGR(2017 - 2029) 6.3% CAGR(2023 - 2029) 7.0% 6.6% Source: Visiongain 2018 Source: Visiongain 2018
  4. 4. www.visiongain.com/industries/pharma Page127 Global Bioreactors Market 2019-2029: 5L-20L, 20L-200L, 200L-1500L, Above 1500L, Single-Use, Glass, Stainless Steel, Lab-Scale, Pilot-Scale, Full-Scale, R&D Departments, Biopharmaceutical Manufacturers, Contract Research Organizations, Other End-Users Figure 9.1 ThermoFisher Scientific Inc. 2017 Annual Revenue by Business Segments Source: Visiongain 2018 Figure 9.2 ThermoFisher Scientific Inc.: Annual Revenue ($m), AGR (%), 2013- 2017 Source: Visiongain 2018 9.1.4 ThermoFisher Scientific Inc. Corporate Strategy The company is focused on providing innovative solutions in order to enhance the operational efficiency. For instance, in 2017, ThermoFisher Scientific strengthened its bioprocessing capabilities with new and innovative products. These new products demonstrate innovations in single-use technologies, cell culture, and protein purification. Life Sciences Solutions, 26.20% Analytical Instruments, 22.10% Speciality Diagnostics, 15.90% Laboratory Products and Services, 35.80% 13,090.3 16,889.6 16,965.4 18,274.1 20,918.0 4.4% 22.5% 0.4% 7.2% 12.6% -20.0% -15.0% -10.0% -5.0% 0.0% 5.0% 10.0% 15.0% 20.0% 25.0% 0 5,000 10,000 15,000 20,000 25,000 2013 2014 2015 2016 2017 Revenue($m)

×